Aza analogues of alkyl lysophospholipids exert immunomodulatory effects
The present invention relates to alkyl lysophospholipid (ALP), and derivatives thereof, that are potent cytokine inducers and immunomodulatory agents. The immunomodulatory agents are administered to a subject having a condition characterized by an altered or aberrant cytokine activity such as, but n...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | BONAVIDA BENJAMIN GAN XIAO-HU |
description | The present invention relates to alkyl lysophospholipid (ALP), and derivatives thereof, that are potent cytokine inducers and immunomodulatory agents. The immunomodulatory agents are administered to a subject having a condition characterized by an altered or aberrant cytokine activity such as, but not limited to, neoplasia, infectious diseases, chronic and acute immune diseases, autoimmunity, transplantation, diseases mediated by nitric oxide and cytokines, adverse drug reactions, obesity, septic shock, and adverse side effects due to cancer chemotherapy. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2001053772A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2001053772A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2001053772A13</originalsourceid><addsrcrecordid>eNrjZHB3rEpUSMxLzMlPL00tVshPU0jMya7MUcipLM4vyMgvBuKczILMlGKF1IrUohKFzNzc0rz83PyU0pzEkvyiSoXUtLTU5JJiHgbWtMSc4lReKM3NoOzmGuLsoZtakB-fWlyQmJyal1oSHxpsZGBgaGBqbG5u5GhoTJwqALrVNf8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Aza analogues of alkyl lysophospholipids exert immunomodulatory effects</title><source>esp@cenet</source><creator>BONAVIDA BENJAMIN ; GAN XIAO-HU</creator><creatorcontrib>BONAVIDA BENJAMIN ; GAN XIAO-HU</creatorcontrib><description>The present invention relates to alkyl lysophospholipid (ALP), and derivatives thereof, that are potent cytokine inducers and immunomodulatory agents. The immunomodulatory agents are administered to a subject having a condition characterized by an altered or aberrant cytokine activity such as, but not limited to, neoplasia, infectious diseases, chronic and acute immune diseases, autoimmunity, transplantation, diseases mediated by nitric oxide and cytokines, adverse drug reactions, obesity, septic shock, and adverse side effects due to cancer chemotherapy.</description><edition>7</edition><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2001</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20011220&DB=EPODOC&CC=US&NR=2001053772A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20011220&DB=EPODOC&CC=US&NR=2001053772A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BONAVIDA BENJAMIN</creatorcontrib><creatorcontrib>GAN XIAO-HU</creatorcontrib><title>Aza analogues of alkyl lysophospholipids exert immunomodulatory effects</title><description>The present invention relates to alkyl lysophospholipid (ALP), and derivatives thereof, that are potent cytokine inducers and immunomodulatory agents. The immunomodulatory agents are administered to a subject having a condition characterized by an altered or aberrant cytokine activity such as, but not limited to, neoplasia, infectious diseases, chronic and acute immune diseases, autoimmunity, transplantation, diseases mediated by nitric oxide and cytokines, adverse drug reactions, obesity, septic shock, and adverse side effects due to cancer chemotherapy.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2001</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHB3rEpUSMxLzMlPL00tVshPU0jMya7MUcipLM4vyMgvBuKczILMlGKF1IrUohKFzNzc0rz83PyU0pzEkvyiSoXUtLTU5JJiHgbWtMSc4lReKM3NoOzmGuLsoZtakB-fWlyQmJyal1oSHxpsZGBgaGBqbG5u5GhoTJwqALrVNf8</recordid><startdate>20011220</startdate><enddate>20011220</enddate><creator>BONAVIDA BENJAMIN</creator><creator>GAN XIAO-HU</creator><scope>EVB</scope></search><sort><creationdate>20011220</creationdate><title>Aza analogues of alkyl lysophospholipids exert immunomodulatory effects</title><author>BONAVIDA BENJAMIN ; GAN XIAO-HU</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2001053772A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2001</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>BONAVIDA BENJAMIN</creatorcontrib><creatorcontrib>GAN XIAO-HU</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BONAVIDA BENJAMIN</au><au>GAN XIAO-HU</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Aza analogues of alkyl lysophospholipids exert immunomodulatory effects</title><date>2001-12-20</date><risdate>2001</risdate><abstract>The present invention relates to alkyl lysophospholipid (ALP), and derivatives thereof, that are potent cytokine inducers and immunomodulatory agents. The immunomodulatory agents are administered to a subject having a condition characterized by an altered or aberrant cytokine activity such as, but not limited to, neoplasia, infectious diseases, chronic and acute immune diseases, autoimmunity, transplantation, diseases mediated by nitric oxide and cytokines, adverse drug reactions, obesity, septic shock, and adverse side effects due to cancer chemotherapy.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_US2001053772A1 |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
title | Aza analogues of alkyl lysophospholipids exert immunomodulatory effects |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T11%3A06%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BONAVIDA%20BENJAMIN&rft.date=2001-12-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2001053772A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |